Published on 15 Oct 2024 on GuruFocus.com · via Yahoo Finance
SILVERARC CAPITAL MANAGEMENT, LLC Reduces Stake in Mersana Therapeutics Inc
On October 11, 2024, SILVERARC CAPITAL MANAGEMENT, LLC (Trades, Portfolio) executed a significant transaction by reducing its holdings in Mersana Therapeutics Inc (NASDAQ:MRSN). The firm sold 746,499 shares at a price of $1.97 per share, which altered its portfolio by -0.35%. This move left SILVERARC with a total of 1,754,086 shares in Mersana Therapeutics, representing a 0.82% position in its portfolio and 1.43% of the company's outstanding shares.
Overview of SILVERARC CAPITAL MANAGEMENT, LLC (Trades, Portfolio)
Warning! GuruFocus has detected 9 Warning Signs with MRSN.